Guotai Haitong: The expected decline in the sixth batch of consumables national procurement is moderate, and domestic manufacturers are expected to increase production.

Guotai Junan Securities released a research report stating that the sixth batch of medical consumables national procurement documents have been released. This collective procurement will be conducted in AB units with multiple rounds of bidding, and it is expected that the price reduction will be moderate. The situation of guaranteed quantity is in line with expectations, and the market share of domestic manufacturers is expected to increase. The pharmaceutical industry maintains a "hold" rating. It is recommended to focus on medical consumable companies that are expected to benefit from the collective procurement and drive sales growth.